Immune cells can become exhausted after prolonged exposure to cancer, gradually losing their ability to attack tumor cells.
Vietnam Investment Review on MSN
Kazia Therapeutics doses first patient in paediatric brain cancer trial
SYDNEY, Sept. 9, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an ...
A breakthrough study from Keck Medicine of USC may have found a powerful new triple therapy for glioblastoma, one of the deadliest brain cancers. By combining Tumor Treating Fields (TTFields), which ...
A new Phase I clinical trial has found that an emerging immunotherapy is promising for the treatment of recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T ...
Brain tumors develop within an organ that changes substantially with age. A new review in Ageing and Cancer Research & ...
Plus, when to call your doctor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results